hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers

Pathological evidence of amyloid on nerve biopsy has been the gold standard for diagnosis in hereditary transthyretin amyloidosis polyneuropathy (hATTR-PN) for a long time. In this article, we reviewed the pathological findings of a large series of sural nerve biopsies from a cohort of hATTR-PN pati...

Full description

Bibliographic Details
Main Authors: Marco Luigetti, Marina Romozzi, Giulia Bisogni, Davide Cardellini, Tiziana Cavallaro, Andrea Di Paolantonio, Gian Maria Fabrizi, Silvia Fenu, Luca Gentile, Marina Grandis, Gianluca Marucci, Sara Massucco, Anna Mazzeo, Davide Pareyson, Angela Romano, Massimo Russo, Angelo Schenone, Matteo Tagliapietra, Stefano Tozza, Giuseppe Vita, Mario Sabatelli
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/10/11/780
id doaj-17201db1317b444c851ed8859b025690
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Marco Luigetti
Marina Romozzi
Giulia Bisogni
Davide Cardellini
Tiziana Cavallaro
Andrea Di Paolantonio
Gian Maria Fabrizi
Silvia Fenu
Luca Gentile
Marina Grandis
Gianluca Marucci
Sara Massucco
Anna Mazzeo
Davide Pareyson
Angela Romano
Massimo Russo
Angelo Schenone
Matteo Tagliapietra
Stefano Tozza
Giuseppe Vita
Mario Sabatelli
spellingShingle Marco Luigetti
Marina Romozzi
Giulia Bisogni
Davide Cardellini
Tiziana Cavallaro
Andrea Di Paolantonio
Gian Maria Fabrizi
Silvia Fenu
Luca Gentile
Marina Grandis
Gianluca Marucci
Sara Massucco
Anna Mazzeo
Davide Pareyson
Angela Romano
Massimo Russo
Angelo Schenone
Matteo Tagliapietra
Stefano Tozza
Giuseppe Vita
Mario Sabatelli
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
Brain Sciences
hATTR
nerve biopsy
amyloid
Congo red
axonal loss
polyneuropathy
author_facet Marco Luigetti
Marina Romozzi
Giulia Bisogni
Davide Cardellini
Tiziana Cavallaro
Andrea Di Paolantonio
Gian Maria Fabrizi
Silvia Fenu
Luca Gentile
Marina Grandis
Gianluca Marucci
Sara Massucco
Anna Mazzeo
Davide Pareyson
Angela Romano
Massimo Russo
Angelo Schenone
Matteo Tagliapietra
Stefano Tozza
Giuseppe Vita
Mario Sabatelli
author_sort Marco Luigetti
title hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
title_short hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
title_full hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
title_fullStr hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
title_full_unstemmed hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers
title_sort hattr pathology: nerve biopsy results from italian referral centers
publisher MDPI AG
series Brain Sciences
issn 2076-3425
publishDate 2020-10-01
description Pathological evidence of amyloid on nerve biopsy has been the gold standard for diagnosis in hereditary transthyretin amyloidosis polyneuropathy (hATTR-PN) for a long time. In this article, we reviewed the pathological findings of a large series of sural nerve biopsies from a cohort of hATTR-PN patients, collected by different Italian referral centers. <b>Patients and Methods:</b> We reviewed clinical and pathological data from hATTR-PN patients, diagnosed and followed in five Italian referral centers for peripheral neuropathies. Diagnosis was formulated after a positive genetic test for transthyretin (<i>TTR</i>) mutations. Sural nerve biopsy was performed according to standard protocols. <b>Results:</b> Sixty-nine sural nerve biopsies from hATTR-PN patients were examined. Congo red positive deposits were found in 73% of cases. Only the Phe64Leu mutation failed to show amyloid deposits in a high percentage of biopsies (54%), as already described. Unusual pathological findings, such as myelin abnormalities or inflammatory infiltrates, were detected in occasional cases. <b>Conclusions:</b> Even if no longer indicated to confirm hATTR-PN clinical suspicion, nerve biopsy remains, in expert hands, a rapid and inexpensive tool to detect amyloid deposition. In Italy, clinicians should be aware that a negative biopsy does not exclude hATTR-PN, particularly for Phe64Leu, one of the most frequent mutations in this country.
topic hATTR
nerve biopsy
amyloid
Congo red
axonal loss
polyneuropathy
url https://www.mdpi.com/2076-3425/10/11/780
work_keys_str_mv AT marcoluigetti hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT marinaromozzi hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT giuliabisogni hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT davidecardellini hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT tizianacavallaro hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT andreadipaolantonio hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT gianmariafabrizi hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT silviafenu hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT lucagentile hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT marinagrandis hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT gianlucamarucci hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT saramassucco hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT annamazzeo hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT davidepareyson hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT angelaromano hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT massimorusso hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT angeloschenone hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT matteotagliapietra hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT stefanotozza hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT giuseppevita hattrpathologynervebiopsyresultsfromitalianreferralcenters
AT mariosabatelli hattrpathologynervebiopsyresultsfromitalianreferralcenters
_version_ 1724539016550809600
spelling doaj-17201db1317b444c851ed8859b0256902020-11-25T03:39:25ZengMDPI AGBrain Sciences2076-34252020-10-011078078010.3390/brainsci10110780hATTR Pathology: Nerve Biopsy Results from Italian Referral CentersMarco Luigetti0Marina Romozzi1Giulia Bisogni2Davide Cardellini3Tiziana Cavallaro4Andrea Di Paolantonio5Gian Maria Fabrizi6Silvia Fenu7Luca Gentile8Marina Grandis9Gianluca Marucci10Sara Massucco11Anna Mazzeo12Davide Pareyson13Angela Romano14Massimo Russo15Angelo Schenone16Matteo Tagliapietra17Stefano Tozza18Giuseppe Vita19Mario Sabatelli20Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Neurologia, 00168 Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS, UOC Neurologia, 00168 Roma, ItalyCentro Clinico NEMO-Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, ItalyDipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, 37134 Verona, ItalyDipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, 37134 Verona, ItalyDipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Roma, ItalyDipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, 37134 Verona, ItalyRare Neurodegenerative and Neurometabolic Diseases Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, 98125 Messina, ItalyDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno Infantili (DINOGMI), Università degli studi di Genova, 16132 Genova, ItalyNeuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, ItalyDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno Infantili (DINOGMI), Università degli studi di Genova, 16132 Genova, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, 98125 Messina, ItalyRare Neurodegenerative and Neurometabolic Diseases Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, ItalyDipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Roma, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, 98125 Messina, ItalyDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno Infantili (DINOGMI), Università degli studi di Genova, 16132 Genova, ItalyDipartimento di Neuroscienze, Biomedicina e Scienze del Movimento, Università di Verona, 37134 Verona, ItalyDipartimento di Neuroscienze, Scienze della Riproduzione e Oftalmologiche, Università Federico II di Napoli, 80131 Napoli, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, 98125 Messina, ItalyDipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Roma, ItalyPathological evidence of amyloid on nerve biopsy has been the gold standard for diagnosis in hereditary transthyretin amyloidosis polyneuropathy (hATTR-PN) for a long time. In this article, we reviewed the pathological findings of a large series of sural nerve biopsies from a cohort of hATTR-PN patients, collected by different Italian referral centers. <b>Patients and Methods:</b> We reviewed clinical and pathological data from hATTR-PN patients, diagnosed and followed in five Italian referral centers for peripheral neuropathies. Diagnosis was formulated after a positive genetic test for transthyretin (<i>TTR</i>) mutations. Sural nerve biopsy was performed according to standard protocols. <b>Results:</b> Sixty-nine sural nerve biopsies from hATTR-PN patients were examined. Congo red positive deposits were found in 73% of cases. Only the Phe64Leu mutation failed to show amyloid deposits in a high percentage of biopsies (54%), as already described. Unusual pathological findings, such as myelin abnormalities or inflammatory infiltrates, were detected in occasional cases. <b>Conclusions:</b> Even if no longer indicated to confirm hATTR-PN clinical suspicion, nerve biopsy remains, in expert hands, a rapid and inexpensive tool to detect amyloid deposition. In Italy, clinicians should be aware that a negative biopsy does not exclude hATTR-PN, particularly for Phe64Leu, one of the most frequent mutations in this country.https://www.mdpi.com/2076-3425/10/11/780hATTRnerve biopsyamyloidCongo redaxonal losspolyneuropathy